To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene KIAA1009TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
119 supporting clones for gene KIAA1009 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CD684914 normal nasopharynx .a 1 to 288 42 to 329   tiling clone,   288/335
(85 %)
10 diff
(97.1 %id)
NM_014895.2   .a 19 to 5155 1 to 5137 exact RefSeq, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 5137/5137
(100 %)
0 diff
(100 %id)
DC424230   .a 19 to 772 1 to 755   tiling clone,   755/759
(99 %)
6 diff
(99.3 %id)
BG024909 lymph, lymphoma, cell line .a 28 to 683 12 to 685   available from MGC,   630/837
(75 %)
24 diff
(97.2 %id)
AK308190   .a 34 to 2444 1 to 2410   tiling clone,   2410/2410
(100 %)
4 diff
(99.9 %id)
DC384318   .a 34 to 590 1 to 557       557/557
(100 %)
2 diff
(99.7 %id)
AA382324 testis .a 57 to 331 1 to 276       276/276
(100 %)
2 diff
(99.3 %id)
DR000204 fetal brain .a 155 to 676 1 to 522       522/522
(100 %)
1 diff
(99.9 %id)
TI_1948230903   .a 340 to 1231 126 to 1014       889/1357
(65 %)
25 diff
(98.2 %id)
TI_1948230904   .a 340 to 1142 123 to 925       803/1214
(66 %)
13 diff
(99.0 %id)
TI_1948231154   .a 340 to 1369 135 to 1151       1017/1429
(71 %)
53 diff
(96.3 %id)
TI_1948231155   .a 340 to 1142 127 to 934       808/1200
(67 %)
18 diff
(98.5 %id)
TI_1948231398   .a 340 to 1230 123 to 1015       893/1439
(62 %)
20 diff
(98.7 %id)
TI_1948231399   .a 340 to 1222 125 to 1012       888/1186
(74 %)
20 diff
(98.4 %id)
TI_1948231649   .a 340 to 1224 126 to 1007       882/1396
(63 %)
19 diff
(98.7 %id)
TI_1948231650   .a 340 to 1293 124 to 1093       968/1176
(82 %)
38 diff
(96.8 %id)
EL737085 mixed .a 344 to 996 1 to 649       649/649
(100 %)
5 diff
(99.3 %id)
DB224254 trachea .a 706 to 1291 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
BX480748   .a 806 to 1229 1 to 424       424/424
(100 %)
0 diff
(100 %id)
AU137750 placenta .a 995 to 1718 2 to 726   capped   725/725
(100 %)
6 diff
(99.2 %id)
BG571270 placenta .a 1031 to 1759 1 to 729       729/769
(94 %)
5 diff
(99.4 %id)
BG620341 placenta .a 1031 to 1775 1 to 745       745/750
(99 %)
4 diff
(99.5 %id)
AU185598 skin .a 1228 to 1722 495 to 1       495/495
(100 %)
0 diff
(100 %id)
DB074377 testis .a 1362 to 1915 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
AW467825 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .a 1522 to 1772 250 to 1       250/286
(87 %)
10 diff
(96.6 %id)
TI_149272873   .a 1981 to 2587 671 to 66   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 606/1076
(56 %)
8 diff
(99.3 %id)
CD557453 testis .a 1990 to 2888 27 to 928   tiling clone,   902/929
(97 %)
12 diff
(98.8 %id)
BU675375 lung, Primary Lung Epithelial Cells .a 2021 to 2587 571 to 6   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 566/571
(99 %)
4 diff
(99.3 %id)
DA591624 lung .a 2023 to 2586 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA780558 brain .a 2123 to 2714 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
AA916436 breast .a 2205 to 2573 370 to 1       370/391
(94 %)
6 diff
(98.5 %id)
BX483150   .a 2333 to 2991 1 to 659       659/659
(100 %)
0 diff
(100 %id)
BE897017 melanotic melanoma, skin .a 2444 to 3242 1 to 795       795/795
(100 %)
20 diff
(97.5 %id)
DA826939 pericardium .a 2457 to 3032 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
CD557794 testis .a 2499 to 3340 60 to 907       846/908
(93 %)
23 diff
(97.5 %id)
DA897127 skeletal muscle .a 2526 to 3077 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
CR996343 T-Lymphocytes .a 2528 to 3041 1 to 513       513/513
(100 %)
1 diff
(99.9 %id)
CN362097 embryonic stem cells, DMSO-treated H9 cellline .a 2633 to 3154 1 to 522   tiling clone,   522/522
(100 %)
0 diff
(100 %id)
CV574585 cornea, eye .a 2835 to 3448 1 to 614       614/614
(100 %)
0 diff
(100 %id)
CN362098 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2896 to 3014 9 to 127       119/127
(93 %)
6 diff
(95.3 %id)
CD519633 White Matter .a 2926 to 3715 1 to 797   tiling clone,   797/884
(90 %)
16 diff
(98.2 %id)
CB215854 normal endometrium, late proliferativephase, cycle day 13, uterus .a 3009 to 3608 1 to 600       600/600
(100 %)
0 diff
(100 %id)
BE177592 head_neck .a 3358 to 3656 310 to 8     Submitted on the opposite strand 303/321
(94 %)
0 diff
(100 %id)
BP377633 uterus .a 3375 to 3960 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BI032759 nervous_normal .a 3588 to 3992 1 to 402       402/402
(100 %)
28 diff
(93.1 %id)
BU929708 placenta .a 3618 to 4364 1 to 749   tiling clone,   749/749
(100 %)
5 diff
(99.4 %id)
TI_149276716   .a 3788 to 4483 775 to 82   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 694/694
(100 %)
2 diff
(99.8 %id)
AA431701.
matches multiple genes
  .a 3805 to 4231 1 to 427     also hits gene ZNF251 427/427
(100 %)
0 diff
(100 %id)
BU608630 Human Lung Epithelial cells, lung .a 3821 to 4483 677 to 16   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 662/675
(98 %)
1 diff
(99.9 %id)
CA429366 Cell Line, Chondrosarcoma .a 3822 to 4480 672 to 15   AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 658/658
(100 %)
1 diff
(99.9 %id)
AV682775 hepatocellular carcinoma .a 3856 to 4486 1 to 631       631/631
(100 %)
3 diff
(99.6 %id)
BU677375 lung, Primary Lung Epithelial Cells .a 3860 to 4483 639 to 16   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 624/624
(100 %)
0 diff
(100 %id)
CA428990 Cell Line, Chondrosarcoma .a 3920 to 4494 579 to 5       575/579
(99 %)
0 diff
(100 %id)
BG897896 cartilage .a 3937 to 4502 32 to 597   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 566/597
(94 %)
8 diff
(98.7 %id)
BG196489   .a 3983 to 4711 1 to 727       727/796
(91 %)
18 diff
(97.8 %id)
AU157300 placenta .a 3987 to 4483 497 to 1       497/596
(83 %)
21 diff
(96.5 %id)
BG212605   .a 3996 to 4776 1 to 780       780/785
(99 %)
7 diff
(99.2 %id)
BG214213   .a 3996 to 4783 1 to 787       787/787
(100 %)
6 diff
(99.3 %id)
AW592426 pooled .a 4118 to 4490 373 to 1       373/373
(100 %)
0 diff
(100 %id)
BE693381 breast .a 4120 to 4305 195 to 11       185/198
(93 %)
0 diff
(100 %id)
W56513 heart .a 4128 to 4484 1 to 358       358/358
(100 %)
1 diff
(99.8 %id)
AI147106 pooled .a 4146 to 4492 347 to 1       347/347
(100 %)
0 diff
(100 %id)
AI446000 adenocarcinoma, Pancreas .a 4162 to 4483 322 to 1       322/331
(97 %)
0 diff
(100 %id)
G43030   .a 4204 to 4456 253 to 1     Submitted on the opposite strand 253/253
(100 %)
0 diff
(100 %id)
BG191919   .a 4207 to 4493 308 to 22   AAA Submitted on the opposite strand 287/288
(99 %)
0 diff
(100 %id)
BQ432920 testis .a 4217 to 4496 1 to 280   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 280/280
(100 %)
3 diff
(99.0 %id)
AA953896 pooled .a 4240 to 4595 356 to 1   tiling clone,   356/356
(100 %)
0 diff
(100 %id)
FN051825 breast carcinoma .a 4283 to 4359 77 to 1     Submitted on the opposite strand 77/78
(98 %)
2 diff
(97.5 %id)
BC127206 PCR rescued clones .a 4296 to 4452 11 to 167       157/175
(89 %)
2 diff
(98.9 %id)
BC127207 PCR rescued clones .a 4296 to 4454 15 to 173       159/179
(88 %)
2 diff
(98.9 %id)
AA938917 pooled .a 4319 to 4490 172 to 1       172/172
(100 %)
0 diff
(100 %id)
BQ084520 stomach .a 4345 to 4728 1 to 384       384/384
(100 %)
4 diff
(99.0 %id)
BM823389 stomach .a 4350 to 4672 1 to 323       323/323
(100 %)
6 diff
(98.2 %id)
FN069217 breast carcinoma .a 4402 to 4493 1 to 91       91/92
(98 %)
2 diff
(97.9 %id)
BQ773838 Chondrosarcoma Grade II, Left Pelvis .a 4486 to 5144 677 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 659/659
(100 %)
0 diff
(100 %id)
BP223299 colon mucosa .a 4507 to 5140 1 to 636       636/649
(97 %)
13 diff
(98.0 %id)
AW069289 bone marrow stroma .a 4519 to 5155 656 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 638/638
(100 %)
2 diff
(99.7 %id)
BQ774437 Chondrosarcoma Grade II, Left Pelvis .a 4578 to 5144 585 to 19   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 567/574
(98 %)
0 diff
(100 %id)
AI400596 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4679 to 5144 466 to 1       466/466
(100 %)
2 diff
(99.6 %id)
BE466485 Kidney .a 4682 to 5147 468 to 3       466/468
(99 %)
0 diff
(100 %id)
AI693494 pooled .a 4693 to 5147 463 to 8       456/463
(98 %)
0 diff
(100 %id)
AA988550 carcinoid, lung .a 4868 to 5140 273 to 1       273/273
(100 %)
0 diff
(100 %id)
AW194210 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 4885 to 5145 269 to 9       261/269
(97 %)
0 diff
(100 %id)
AB023226 brain .b 1 to 5051 1 to 5051 S92I tiling clone, available from KIAA,   5051/5051
(100 %)
1 diff
(100.0 %id)
AK023613 placenta .c 1 to 3493 2 to 3494 exact tiling clone, available from FLJ,   3494/3494
(100 %)
2 diff
(100.0 %id)
TI_1948231400   .c 145 to 944 928 to 129       800/1494
(53 %)
3 diff
(99.8 %id)
BC063632 Lymph, lymphoma .d 1 to 2053 1 to 2053 exact tiling clone, available from MGC, AAA   2053/2053
(100 %)
2 diff
(100.0 %id)
TI_1948231156   .d 923 to 1911 1107 to 130       978/1366
(71 %)
40 diff
(97.1 %id)
TI_1948231651   .d 951 to 1911 1081 to 128       954/1375
(69 %)
24 diff
(98.3 %id)
TI_1948230905   .d 1010 to 1911 1025 to 127       899/1320
(68 %)
8 diff
(99.4 %id)
BF364064 nervous_normal .e 1 to 370 369 to 1   tiling clone,   369/369
(100 %)
4 diff
(99.0 %id)
DA405311 thalamus .e 129 to 604 2 to 477   tiling clone, capped   476/476
(100 %)
0 diff
(100 %id)
DB312361 thalamus .e 1396 to 1927 534 to 1   tiling clone,   534/534
(100 %)
2 diff
(99.7 %id)
BU622745 cell lines, Chondrosarcoma .f 1 to 777 793 to 19 F6X A8L L9Y H10I S11V ... tiling clone, AAA   775/775
(100 %)
2 diff
(99.8 %id)
DB056250 testis .g 1 to 559 2 to 561   tiling clone, capped   560/560
(100 %)
2 diff
(99.7 %id)
BI825870 brain, medulla .g 22 to 793 1 to 771 L210C H211T S212Q S213V G215E ... tiling clone,   771/771
(100 %)
1 diff
(99.9 %id)
TI_57174014   .g 22 to 793 37 to 807 L210C H211T S212Q S213V G215E ...     771/807
(95 %)
7 diff
(99.2 %id)
BX280084 brain, medulla .g 23 to 539 1 to 517       517/517
(100 %)
0 diff
(100 %id)
DB180291 kidney, tumor tissue .h 1 to 551 2 to 553   tiling clone, capped   552/552
(100 %)
2 diff
(99.7 %id)
BU679808 lung, Primary Lung Epithelial Cells .h 452 to 1039 604 to 16 N41I tiling clone, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 589/589
(100 %)
5 diff
(99.2 %id)
BG199030   .h 539 to 1039 1 to 500 E8X K10E I11W K12G Q13R ... AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 500/500
(100 %)
13 diff
(97.4 %id)
BG208932   .h 539 to 883 1 to 344 exact     344/344
(100 %)
3 diff
(99.2 %id)
BG192965   .h 540 to 1040 1 to 501 E8X K10E I11W K12G Q13R ... AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 501/503
(99 %)
16 diff
(96.9 %id)
BG215258   .h 541 to 1042 3 to 503 E8X I11M K12E T63R AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 501/503
(99 %)
7 diff
(98.7 %id)
BG203672   .h 544 to 1039 63 to 559 exact AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 496/559
(88 %)
17 diff
(97.0 %id)
BG202114   .h 546 to 1296 8 to 756 E59D tiling clone,   749/773
(96 %)
46 diff
(94.1 %id)
CB162590 Liver .h 547 to 1042 1 to 495 exact AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 495/495
(100 %)
1 diff
(99.8 %id)
CB164178 Liver .h 547 to 1042 1 to 496 I29F Q30H Q31* AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 496/496
(100 %)
5 diff
(99.0 %id)
BG211012   .h 554 to 715 1 to 162       162/162
(100 %)
3 diff
(98.2 %id)
BG194843   .h 559 to 860 1 to 302       302/302
(100 %)
10 diff
(96.7 %id)
AI432332 pooled .h 583 to 1041 461 to 3 exact     459/461
(99 %)
0 diff
(100 %id)
AI474053 Kidney .h 640 to 1057 419 to 2   tiling clone,   418/419
(99 %)
0 diff
(100 %id)
DB347553 kidney, tumor tissue .h 1422 to 1931 510 to 1   tiling clone,   510/510
(100 %)
0 diff
(100 %id)
DB084129 testis .i 1 to 565 2 to 566 exact tiling clone, capped   565/565
(100 %)
1 diff
(99.9 %id)
DA949367 Spleen .i 3 to 559 2 to 559 E11G L20X S21F D22R D23* capped   558/558
(100 %)
2 diff
(99.7 %id)
DA745137   .i 14 to 585 2 to 573 exact tiling clone, capped   572/572
(100 %)
0 diff
(100 %id)
AA702958 liver and spleen .j-u 1 to 455 453 to 1 W14C L15H T16A P17C V18N ... tiling clone,   453/453
(100 %)
2 diff
(99.6 %id)
DB310385 substantia nigra Gene KIAA1009, variant not shown         This clone was ignored    
DA351966 substantia nigra Gene KIAA1009, variant not shown       capped This clone was ignored    
Z39374 brain, total brain Gene KIAA1009, variant not shown              
Z43299 brain, total brain Gene KIAA1009, variant not shown              
R35585 whole brain Gene KIAA1009, variant not shown              
DB063068 testis Gene KIAA1009, variant not shown       capped Suspected internal deletion, this clone was ignored    
TI_149282180   Gene KIAA1009, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI